ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ACCD Accolade Inc

6.89
0.015 (0.22%)
01 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Accolade Inc NASDAQ:ACCD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.015 0.22% 6.89 6.83 6.94 6.91 6.87 6.87 1,637,733 01:00:00

Accolade To Present at Upcoming Investor Conferences

13/11/2024 1:00pm

GlobeNewswire Inc.


Accolade (NASDAQ:ACCD)
Historical Stock Chart


From Nov 2024 to Feb 2025

Click Here for more Accolade Charts.

Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolade.com and a replay will be available for 90 days.

  • Stephens Annual Investment Conference | NASH2024 in Nashville on Wednesday, November 20 at 9:00 am CT
  • CG MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 21. (1x1 meetings, no webcast)
  • Piper Sandler 36th Annual Healthcare Conference in New York on Thursday, December 5 at 10:00 am ET.

About Accolade, Inc.

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedIn, Twitter, Instagram and Facebook.

Investor Contact:

Todd Friedman, Investor Relations, IR@accolade.com

1 Year Accolade Chart

1 Year Accolade Chart

1 Month Accolade Chart

1 Month Accolade Chart

Your Recent History

Delayed Upgrade Clock